Director Thought Leader Liaison
Invivyd
Director Thought Leader Liaison
Invivyd
Develops monoclonal antibodies for viral protection
ABOUT US
There are more than 9 million immunocompromised people in the United States. Almost half a million of those represent a population that are moderately to severely immunocompromised and at highest risk for severe COVID-19, including stem cell and solid organ transplant patients as well as those with hematologic cancers.
At Invivyd, Inc., we take those numbers very seriously and we come to work each day on a mission to deliver protection from serious viral infectious diseases, beginning with SARS-CoV-2. Invivyd deploys a proprietary integrated technology platform unique in the industry designed to assess, monitor, develop, and adapt to create best in class antibodies.
In March 2024, Invivyd received emergency use authorization (EUA) from the U.S. FDA for a monoclonal antibody (mAb) in its pipeline of innovative antibody candidates.
In October 2025, the FDA cleared the company's Investigational New Drug (IND) application and provided feedback to advance the company's REVOLUTION clinical program, Invivyd's development program for VYD2311, a vaccine alternative monoclonal antibody being investigated for the prevention of COVID-19.
Be part of making a difference. Be part of Invivyd.
Location: Boston, CT
Position Summary:
We are seeking a dynamic and self-motivated Director, Thought Leader Liaison to lead field marketing efforts, including Key Opinion Leader identification and management, Speaker Bureau Management, and local/ regional Patient Advocacy Engagements.
The ideal candidate will bring a strong field marketing background, excellent communication skills, and a proven ability to build meaningful relationships with both healthcare professionals and patients.
Responsibilities:
Requirements:
Pay Range
$184,000 - $245,000
The pay range represents the expected full-time base salary for this role at the time of posting. Actual base pay will be determined based on a variety of factors, including relevant experience, skills, and education. In addition to base pay, this role is eligible for both an annual short-term incentive (e.g., bonus or sales incentive) and an annual long-term incentive (e.g., equity), reflecting our commitment to rewarding strong performance and long-term impact. Learn more about our total rewards by visiting https://www.invivyd.com/careers/.
At Invivyd we strive to create a welcoming and inclusive environment. Here all applicants will receive equal consideration for employment without discrimination on the basis of race, color, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, disability, or any other applicable legally protected characteristics.
Invivyd is proud to be an equal opportunity employer.
We do not accept unsolicited resumes from agencies.
Invivyd develops antibody-based therapies to protect immunocompromised people from viral threats. It discovers and optimizes monoclonal antibodies using viral surveillance, predictive modeling, and antibody engineering, starting with COVID-19 and potentially expanding to influenza and other high-need indications; its lead candidate VYD222 aims to prevent symptomatic COVID-19 in high-risk groups. Unlike vaccines-focused approaches, Invivyd delivers externally produced antibodies that neutralize viruses in the body, guided by surveillance and modeling to target vulnerable populations. The goal is to bring antibody therapies to market through development, regulatory approvals, and commercialization, supported by partnerships and government funding to reach those most in need.
Explore more opportunities at Invivyd